Clinical Trial Update: Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Neu2000KWL for acute ischemic stroke within 6 hours of onset completed; study evaluated efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Drugs mentioned

• Neu2000KWL

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Stroke, Cerebral Infarction | Phase 2 | Status: COMPLETED